Immunofluorescence Assay Market is Expected to Reach USD 2.01 Billion by 2023

The Report “Immunofluorescence Assay Market by Product (Reagent, Primary & Secondary Antibody, Kit, Imaging Equipment, Immunofluorescence Microscopy), Type (Direct, Indirect), Disease (Cancer, Cardiovascular, Infectious Disease) & End User — Global Forecast to 2023

Immunofluorescence assay is a powerful technique used to analyze the distribution of glycans, proteins, and small biological and non-biological molecules (cells and tissues) using antibodies conjugated with a fluorescent dye, known as fluorophore, which can be visualized using a fluorescence microscope or imaging systems.

The immunofluorescence assay market is expected to reach USD 2.01 Billion by 2023 from USD 1.43 Billion in 2017, at a CAGR of 5.8%.

The increasing prevalence of chronic diseases, increasing R&D spending, and increasing healthcare spending are the major factors driving the growth of the market. The base year considered for the study is 2017 and the forecast period includes 2018 to 2023.

To know about the assumptions considered for the study, download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255585571

The report analyzes the global market by product, type, disease, end user, and region. On the basis of product, the reagents segment accounted for the largest share of the global market in 2017. The growing applications of biosciences and biotechnology within the pharmaceutical and healthcare fields, the rising prevalence of a number of diseases, growing R&D activities, and government initiatives to strengthen national research capabilities are the factors attributing for the largest share of the reagents segment.

Geographically, the global market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2017, North America accounted for the largest share of the market, followed by Europe and Asia Pacific. The rising incidence of chronic diseases, increasing R&D spending, increasing research activities, favorable government funding opportunities, and the presence of key players in this region are the major factors driving the growth of the immunofluorescence assay market in North America.

The prominent players in the global immunofluorescence assay market are Thermo Fisher (US), Inova Diagnostics (US), Bio-Rad (US), Abcam (UK), PerkinELmer (US), Merck Millipore (US), Cell Signaling Technology (US), MEDIPAN GMBH (Germany), Sino Biological (China), Danaher (US), and Vector Laboratories (US).

Read More

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: 1–888–600–6441

Email: sales@marketsandmarkets.com

Comments

comments

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *